Patent · US Active

Optimized multi-epitope constructs and uses thereof

US7888472B2 · kind B2 · utility

9Cited by
1References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 20, 2009
Grant dateFeb 15, 2011
Priority date
Expiry dateMar 20, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2730/10134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.